CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,310 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 751 shares (option exercise)
- 4 Exercise or conversion Director acquired 751 shares (option exercise)
- 4 Exercise or conversion Director acquired 751 shares (option exercise)
- 4 Exercise or conversion Director acquired 751 shares (option exercise)
- 4 Open-market sale 10% owner sold 125,000 shares at an average $14.64 ($1,830,620)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 644 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 504 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,327 shares (to pay taxes)
Page 10 of 13 · 247 filings